| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $65.9M | $78.1M | $37.9M |
| YoY Revenue Growth % | -15.6% | +106.0% | — |
| Gross Profit | $13.8M | $22.2M | — |
| Gross Margin % | 20.9% | 28.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$101.2M | -$47.5M | -$32.4M |
| Operating Margin % | -80.0% | -60.8% | -80.0% |
| Net Income (GAAP) | -$86.1K | -$47.8K | $99.8K |
| EBITDA (Normalized) | -$85.7M | -$29.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$89.5M | -$44.0M | -$15.4M |
| Capital Expenditures (CapEx) | $19.3M | $22.2M | — |
| Free Cash Flow (FCF) | -$108.7M | -$66.1M | -$15.4M |
| FCF Margin % | -80.0% | -80.0% | -40.6% |
| Return on Invested Capital (ROIC %) | -13.0% | -7.7% | — |
| Cash & Short-Term Equivalents | $64.7M | $38.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $678.4M | $527.8M | — |